Moderna's Stock Surges 50% Prior to U.S. Stock Market Opening
2026-08-19 / Read about 0 minute
Author:小编   

Prior to the opening of the U.S. stock market, Moderna's stock experienced a remarkable 50% surge, following a joint announcement by the company and Merck that their melanoma skin cancer vaccine had successfully met the anticipated outcomes in a large-scale trial.